RMD
RESMED INCData as of 2026 Q2 (06-30) · 13F snapshot
Summary
RESMED INC (RMD) is held as common stock by 5 tracked hedge-fund managers, with a combined reported value of ~$168.54M; the largest are Ken Griffin, Izzy Englander, Joel Greenblatt. 4 tracked managers also disclosed PUT or CALL positions, reported separately below. This quarter: 1 new, 3 added, 1 trimmed, 2 closed. 20 public STOCK Act / OGE trade disclosures are on record. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Mixed
Common-stock holders54 also report options
Congress trades20
Price$222.83vs quarter-end+14.34%
Sectors1
This quarter's moves
Top holderNew1
Added3
Trimmed / sold3
Ken GriffinCommon-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
| Investor | Value | % of portfolio | Action |
|---|
PUT / CALL disclosures
Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.
Value $10.74M— of portfolio55,1002026 Q2
Value $9.18M— of portfolio47,1002026 Q2
Value $4.46M— of portfolio22,9002026 Q2
Value $1.81M— of portfolio9,3002026 Q2
Value $857.5K— of portfolio4,4002026 Q2
Value $233.9K— of portfolio1,2002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Ken GriffinCALL | $10.74M | — | — |
| Ken GriffinPUT | $9.18M | — | — |
| Izzy EnglanderCALL | $4.46M | — | — |
| Izzy EnglanderPUT | $1.81M | — | — |
| Paul Tudor JonesCALL | $857.5K | — | — |
| Steven CohenCALL | $233.9K | — | — |
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.